CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · New debt or obligation
- 8-K/A Event Other events
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Change in control · Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- SC 13G/A Stake Amended Statement of Ownership
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 71 of 74 · 1,466 filings